Literature DB >> 9714052

p53 expression and risk factors for cutaneous melanoma: a case-control study.

D C Whiteman1, P G Parsons, A C Green.   

Abstract

Epidemiological data strongly implicate sunlight as the principal environmental cause of melanoma; however, critical molecular targets for ultraviolet (UV)-induced melanoma remain to be identified. The p53 tumor suppressor gene is one possible target, being abnormally expressed in 20-40% of primary melanomas. We undertook a population-based molecular epidemiological study with the aim of determining the environmental and phenotypic factors associated with p53-positive and p53-negative melanomas. One hundred fifty cases of melanoma were randomly ascertained from the Queensland Cancer Registry and matched to 150 electoral roll controls. Data on environmental and phenotypic exposures were collected through interviews and physical examination of all participants. Sections of tumor tissue were obtained from 134 (89%) cases and stained with the anti-p53 DO-7 monoclonal antibody (MAb) following microwave antigen retrieval. Of 121 useable sections, 22 tumors (18%) had more than 1% cells with positive staining consistent with abnormalities in p53 expression. Strongest predictors of p53-positive melanoma were inability to tan [odds ratio (OR) 6.8], history of non-melanoma skin cancer (OR 3.2) and site of melanoma: head/neck (OR 2.2) and lower limbs (OR 2.3). In contrast, factors such as nevus density and freckling propensity were strongly associated only with p53-immunonegative melanoma (OR 8.6 for >25 moles; OR 3.0 for heavy facial freckling). Overall, the determinants of p53-positive and p53-negative melanomas were independent and complementary, the former being associated with features of sun-sensitivity and chronic sun exposure, the latter with phenotypic markers of melanocytic proliferation. Our findings are consistent with at least 2 independent pathways in the pathogenesis of melanoma, characterized by environmental induction and p53 overexpression on the one hand and pigment cell instability on the other.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714052     DOI: 10.1002/(sici)1097-0215(19980911)77:6<843::aid-ijc8>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

Authors:  J S Palmer; D L Duffy; N F Box; J F Aitken; L E O'Gorman; A C Green; N K Hayward; N G Martin; R A Sturm
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Authors:  Nicholas J Taylor; Nancy E Thomas; Hoda Anton-Culver; Bruce K Armstrong; Colin B Begg; Klaus J Busam; Anne E Cust; Terence Dwyer; Lynn From; Richard P Gallagher; Stephen B Gruber; Diane E Nishri; Irene Orlow; Stefano Rosso; Alison J Venn; Roberto Zanetti; Marianne Berwick; Peter A Kanetsky
Journal:  Int J Cancer       Date:  2016-05-30       Impact factor: 7.396

3.  Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.

Authors:  Sungshim Lani Park; Loïc Le Marchand; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-13

Review 4.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Authors:  David C Whiteman; William J Pavan; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2011-08-16       Impact factor: 4.693

Review 5.  Environmental effects of stratospheric ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2019.

Authors:  G H Bernhard; R E Neale; P W Barnes; P J Neale; R G Zepp; S R Wilson; A L Andrady; A F Bais; R L McKenzie; P J Aucamp; P J Young; J B Liley; R M Lucas; S Yazar; L E Rhodes; S N Byrne; L M Hollestein; C M Olsen; A R Young; T M Robson; J F Bornman; M A K Jansen; S A Robinson; C L Ballaré; C E Williamson; K C Rose; A T Banaszak; D -P Häder; S Hylander; S -Å Wängberg; A T Austin; W -C Hou; N D Paul; S Madronich; B Sulzberger; K R Solomon; H Li; T Schikowski; J Longstreth; K K Pandey; A M Heikkilä; C C White
Journal:  Photochem Photobiol Sci       Date:  2020-05-20       Impact factor: 3.982

6.  MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.

Authors:  N F Box; D L Duffy; W Chen; M Stark; N G Martin; R A Sturm; N K Hayward
Journal:  Am J Hum Genet       Date:  2001-08-08       Impact factor: 11.025

7.  Cutaneous melanoma: hints from occupational risks by anatomic site in Swedish men.

Authors:  B Perez-Gomez; M Pollán; P Gustavsson; N Plato; N Aragonés; G López-Abente
Journal:  Occup Environ Med       Date:  2004-02       Impact factor: 4.402

8.  Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.

Authors:  William F Anderson; Ruth M Pfeiffer; Margaret A Tucker; Philip S Rosenberg
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

9.  The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.

Authors:  Amanda J Baxter; Maria Celia Hughes; Marina Kvaskoff; Victor Siskind; Sri Shekar; Joanne F Aitken; Adele C Green; David L Duffy; Nicholas K Hayward; Nicholas G Martin; David C Whiteman
Journal:  Twin Res Hum Genet       Date:  2008-04       Impact factor: 1.587

10.  [Molecular heterogeneity of malignant melanomas].

Authors:  K Glatz
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.